MedTrace Logo

Safety and Efficacy Study of Topical Cantharidin for the Treatment of Molluscum Contagiosum

NCT02665260 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2017-05-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if cantharidin is a safe and effective treatment for molluscum contagiosum in kids

Conditions

  • Molluscum Contagiosum

Interventions

DRUG

Cantharidin

cantharidin 0.7% topical liquid

DRUG

Placebo

Placebo topical liquid

DEVICE

Gauze occlusion bandage

Gauze occlusion bandage with adhesive tape

Sponsors & Collaborators

  • Montefiore Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2015-11-30
Completion
2016-01-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02665260 on ClinicalTrials.gov